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Significance of lactic acid accumulation after expo-
sure to iodinated contrast media in diabetic pati-
ents receiving metformin
Abdulrahman Al-Moghairi, Ali Almasood, Rahim
Gul, Fadwa Alkhuraisi, Hussein Al-Amri
Background: Metformin is a biguanide oral hypogly-
cemic agent with cardio protective effect. Lactic acidosis
is a rare fatal adverse effect of metformin (0.01–0.15 per
1000 patients). Administration of intravenous iodinated
contrast media during radiologic procedures may lead
to acute decline in renal function (0.1–13%) and subse-
quent lactic acidosis in patients receiving metformin
therapy. No clinical trials tested the extent of lactic acido-
sis in diabetic patients exposed to contrast media.
Objective: This study aimed to investigate the corre-
lation of lactic acid accumulation with clinical outcome in
metformin treated diabetic patients exposed to contrast
media.
Methods: A single-center, prospective single arm
clinical observational trial involved diabetic patients on
metformin therapy undergoing cardiac catheterization.
The study endpoints are drawn from laboratory and clin-
ical outcomes. Patients with acute renal dysfunction or
deterioration were excluded from the study. The patients
were followed at baseline, and 72 h for clinical and labo-
ratory assessment. The primary end point was clinically
significant lactic acidosis.
Results: 156 diabetic patients on metformin were
enrolled in this study with mean age of 61.8 ± 10.4, 84%
were males. Lactic acid, bicarbonate, and pH levels, at
baseline and 72 h were; (1.7 ± 1.2 & 2.1 ± 1.8, p
value = 0.016), (24.4 ± 2.0 & 24.6 ± 3.2, p = 0.7), and
(7.37 ± 0.05 & 7.36 ± 0.06, p = 0.44), respectively. All
patients were clinically stable at 3 days follow up, no
reported death or significant adverse events duringthe
study period.
Conclusion: In contrast to the current recommenda-
tions, continuing use of metformin duringcontrast expo-
sure in high risk population was found to be safe and
not associated with clinically significant lactic acidosis.
http://dx.doi:10.1016/j.jsha.2013.03.028
Use of combination of mitral clip and CGMP-
specific phosphodiesterase type 5 inhibitor as
bridge for cardiac transplantation
Ali Almasood, Hatem Khairallah, Aijaz Shah,
Moheeb Alabdallah, Mohamed Alotaibi,
Abdulrahman Al-Moghairi
Introduction: Severe mitral regurgitation (MR) and
severe pulmonary hypertension (PH) are common conse-
quence of advanced end stage heart failure (HF). Cardiac
transplantation is the only available treatment modality
with reasonable long term outcome for end stage HF.
Presence of severe resistant PH could preclude trans-
plantation. We reported two cases with end stage heart
failure and NYHA class III, who have been initially
turned down from cardiac transplantation because of
severe PH, and we managed to bridge them with mitral
clip and Sildenafil to be transplant eligible. Description
of the cases.
Case 1: First patient is 50 years old gentleman, who is
known to have ischemic cardiomyopathy, ejection frac-
tion (EF) of 15%, and severe MR, with significant func-
tional limitation (NYHA class III) despite of maximum
medical therapy. His pulmonary arterial systolic pressure
(PASP) was 80 mmHg, TPG = 30 mmHg, pulmonary cap-
illary wedge pressure (PCWP) = 33. After full evaluation
he underwent successful deployment of mitral clip and
started on seldanifl 25 mg three times daily, hoping this
will lower the PASP to an acceptable level, to allowlisting
for cardiac transplantation. Echocardiographic assess-
ment after one month of treatment showed that esti-
mated PASP of 40 mmHg.
Case 2: Second patient is 75 y old, who is known to
have ischemic cardiomyopathy, status post three vessels
angioplasty, with EF of 25%, and severe MR. He was very
symptomatic despite maximum medical therapy. He was
deemed not suitable for cardiac transplantation, because
of severe pulmonary hypertension; PASP = 85 mmHg,
mean PA = 59 mmHg, PCWP = 38 mmHg. He underwent
successful deployment of mitral clip and started on silde-
nafil 25 mg three times daily. At one month follow up
PASP went down to 45 mmHg.
Conclusion: We report for first time a successful use
of mitral clip and sildenafil treatment as a bridge to trans-
plant eligibility, for those who have severe MR and
PHTN secondary to advances heart failure. These
patients may not be otherwise suitable transplant
candidate.
This case report brings a new hope for selected high
risk HF patients, with severe MR and severe PHTN.
http://dx.doi:10.1016/j.jsha.2013.03.029
Management of multiple ventricular septal defec-
ts: Evolution of surgical technique
Adel Ragheb, Seifeldin Bashir, Al Otay
Abdulmajeed, Yahia Alfaraidi, Howida
Alqathamy, Roberto M. Di Donato
Background: Residual ventricular septal defects
(VSDs), ventricular and septal dysfunction and heart
block are frequent complications in surgical management
of multiple VSDs (Swiss cheese heart). The technique
with the lowest risk of morbidity and mortality has still
to be identified.
Methods: Between January 200 and September 2012,
45 patients with a median age of 4.1 years (2 months to 15
years) underwent surgical closure of multiple VSDs. In 22
cases there were associated lesions. Two-stage repair, i.e.
pulmonary artery banding (PAB) followed by VSDs clo-
sure using different techniques, was adopted in 29 cases
A
BSTR
A
C
TS
116 ORAL AND POSTER ABSTRACTS J Saudi Heart Assoc
2013;25:113–172
(group A). Primary repair was performed in 15 cases
(group B). Six out of these 15 cases were managed by
the so-called sandwich technique (group B1), whereas
in the other nine other techniques of closure were used
(group B2).
Results: The overall mortality was 8.9% (4/45). Three
of the four deaths occurred in group A and one in group
B2. Follow-up of group A showed that 26 patients had
residual VSDs (2 of whom needing early redo surgery),
2 patients had left ventricular dysfunction and one
patient developed heart block. In group B1, there were
five cases with residual VSDs. In group B2, there were
five cases with residual VSDs (only one needing redo sur-
gery), one case with left ventricular dysfunction and one
case with heart block.
Conclusion: Primary repair of multiple VSDs is asso-
ciated with less morbidity and mortality than staged
repair. The sandwich technique has the lowest risk of
residual VSDs, septal dysfunction and heart block com-
pared to the other techniques. However, particular atten-
tion is needed in positioning the left-sided patch to avoid
septal bulging with consequent left ventricular outflow
tract obstruction and interference with mitral valve chor-
dae with secondary mitral regurgitation.
http://dx.doi:10.1016/j.jsha.2013.03.030
Quality of medical management in coronary artery
disease
Owayed Al Shammeri, Ahlam Alzenaidi,
Randall Stafford, Bushra Al-Huthaly,
Alaa Abdulmonem, Mohammad Abdulzaher
Background: Patients with coronary artery disease
are at high risk of recurrent CAD events. Such risk can
be diminished through guideline recommend optimal
medical therapy (OMT), defined as adherence to dual
antiplatelet therapy, statins, beta blockers and angioten-
sin converting enzyme inhibitors, blood pressure <140/
90 mm Hg (<130/80 mm Hg in diabetics and renal disease
patients), LDL <2 mg/dl, smoking cessation and aerobic
physical activity of 30 min a day for 3 days a week, and
(in diabetics) Hemoglobin A1c <7%.
Aim: To estimate the rate of achieving OMT in CAD
patients in Qassim Province.
Methods: This observational study enrolled 207 con-
secutive CAD patients seen in cardiology clinic in Prince
Sultan Cardiac Center in Qassim between April 1, 2012 to
May 30, 2012. Eligible participants were all documented
CAD patients agreed to participate.We collected the
demographic, medication, laboratory, and clinical data
through in-person interviews,medical records, and an
electronic patient database.
Results: OMT was achieved in only 10.4% of CAD
patients. The OMT rate was 25.5%when the physical
activity requirement (achieved in only 30% of patients)
was excluded. Diabetes was common (64% of all patients)
and only 25% of these patients achieved the target hemo-
globin A1c. The rate of achievement of target systolic
blood pressure was 77%, target diastolic blood pressure
92%, target LDL 68%, adherence to medications 90.8%
and 90% were non-smokers.
Conclusion: Optimal medical therapy is poorly
achieved in Coronary artery disease patients.
This observation warrants investment in strategies to
achieve OMT in these highrisk patients.
http://dx.doi:10.1016/j.jsha.2013.03.031
Placement of balloon-expandable stents in coarca-
tion of the aorta: Initial results and short-term fo-
llow up
Ismail Abri, Ahmed Al Omrani, Mansour Aljoufan,
Fadel Alfadley
King Faisal Specialist Hospital and Research Centers,
Riyadh, Saudi Arabia
Objectives: We report preliminary result and short
term follow up (up to 5 years)of balloon-expandable
stents for the coarctation of the aorta (COA).
Background: Using balloon-expandable stents
gained acceptance over the past years, as a modality of
treatment for COA. However, use of these stents may
create disruption of the aortic wall or aneurysm at the
stents end points.
Our experience using Palmaz stent in half of the
patients mounted on a balloon dilatation catheter. The
rest of the patients received Covered CP Stent. All
patients had significant improvement without any
complications.
Methods: Twenty five patents with mean age 18
years range from 9 to 45 with COA underwent stent
implantation. Nine patients were diagnosed with native
COA and 16 had previous surgical, balloon dilatation or
both, to relieve their coarcation; but had residual/recur-
rent gradient.
A femoral vessels access performed for such proce-
dure and angio-grams were obtained pre and post stent
implantation. BP was continuously monitored during
the procedure.
All patients were maintained on aspirin for at least 6
months post procedure.
Results: Immediately after stent implantation the
peak systolic gradient (mean (SD)) fell from 35 mm Hg
(15.6) to 3.8 (4.3) (mm Hg). (p < 0.05). The diameter of
the stenotic lesion increased from 6.5 (3.0) to13.5
(3.0) mm (p < 0.05). There were no deaths or procedure
related complications. Measured one day after stent
placement, the descending aorta velocity dropped from
(mean (SD)) 3.7 (0.58) m/s to 2.3 (0.6) m/s. (p < 0.05). At
median follow up of 24 months, the clinical gradient
dropped from (mean (SD)) 36 (18) mm Hg pre interven-
tion to 4 (9) p < 0.05) mm Hg. Seven patient (28%)
required re-dilatation at a later stage for re-stenosis.
The average systolic and diastolic blood pressure at
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